Veeva Systems (VEEV) News
NYSE: VEEVTechnologyComputer Software: Prepackaged SoftwareUSD
296.13+11.29 (+3.96%)
At close: Oct 9, 4:01 PM ET · Delayed 15 min
VEEV news summary
We found 35 recent headlines mentioning Veeva Systems (VEEV): 6 in the past week and 23 in the past 30 days, most often from Nasdaq, Seeking Alpha, Investor's Business Daily. For price context, VEEV is up 3.96% at $296.13. The most recent story, "Reasons to Hold Veeva Systems Stock in Your Portfolio for Now", was published by Nasdaq on Oct 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Veeva Systems headlines
- Reasons to Hold Veeva Systems Stock in Your Portfolio for NowVEEV's strong second-quarter results, Vault CRM migrations and AI expansion support growth, while market saturation remains a key concern.NasdaqVEEV, WST, GMED, VCYT
- 2 Growth Stocks to Buy in OctoberKey PointsGrail’s stock could skyrocket if the FDA approves Galleri.NasdaqMRK, LLY, PFE, VEEV
- Software Leader Veeva Systems Positioned To Hit Buy Points After Nearly DoublingVeeva stock is approaching multiple buy points after nearly doubling in recent months, as the stock market rally continues. The post Software Leader Veeva Systems Positioned To Hit Buy Points After…Investor's Business Daily
- Aufstrebende Biotech-Unternehmen setzen einheitlich auf Veeva Basics, um die Arzneimittelentwicklung zu beschleunigenMehr als 175 Biotech-Unternehmen nutzen vorkonfigurierte Anwendungen, um ihre Abläufe zu optimieren PLEASANTON, Kalifornien, 7. Oktober 2026 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) gab heute…PR Newswire
- Veeva's DQS Scales Data Automation Across 1,000+ Clinical StudiesVEEV's DQS cleans clinical trial data for over 1 million subjects across 1,000+ studies, expanding automation in clinical data management.NasdaqVEEV, WST, GMED, VCYT
- Veeva's OpenData to Help Servier Build a Global AI Data FoundationVEEV's OpenData deal with Servier across 80+ countries strengthens its Data Cloud role as life sciences firms scale AI and advanced analytics.NasdaqVEEV, WST, GMED, VCYT
- Veeva Systems (VEEV) Stock Sinks As Market Gains: What You Should KnowVeeva Systems (VEEV) reached $273.25 at the closing of the latest trading day, reflecting a -3.08% change compared to its last close.Nasdaq
- Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for InvestorsVeeva Systems (VEEV) closed the most recent trading day at $281.93, moving 1.23% from the previous trading session.Nasdaq
- Veeva Systems Inc. (VEEV) Is a Trending Stock: Facts to Know Before Betting on ItVeeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.Nasdaq
- Veeva Systems: Same Old Story, Same Rating Once AgainSeeking Alpha
- Brokers Suggest Investing in Veeva (VEEV): Read This Before Placing a BetBased on the average brokerage recommendation (ABR), Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this…Nasdaq
- Veeva Systems: Excellent Execution, But Upside Potential Has Waned (Rating Downgrade)Seeking Alpha
- Veeva Systems (VEEV) Outperforms Broader Market: What You Need to KnowVeeva Systems (VEEV) closed the most recent trading day at $280.68, moving +2.12% from the previous trading session.Nasdaq
- Veeva Unveils AI Study Builder Agent to Speed Clinical Trial SetupVEEV's AI-powered Study Builder Agent automates clinical study setup, cutting manual work while strengthening its connected Clinical Data ecosystem.NasdaqVEEV, WST, GMED, VCYT
- Veeva (VEEV) Down 2.6% Since Last Earnings Report: Can It Rebound?Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.Nasdaq
- Veeva Systems gains new top 20 biopharma win for Vault CRMSeeking Alpha
- Veeva Unveils Falcon Router to Streamline Biopharma Case RoutingVEEV launches Falcon Router to automate biopharma case routing, deepening AI integration across regulated life sciences workflows.NasdaqVEEV, WST, GMED, VCYT
- Here's How Much a $1000 Investment in Veeva Systems Made 10 Years Ago Would Be Worth TodayInvesting in certain stocks can pay off in the long run, especially if you hold on for a decade or more.Nasdaq
- Veeva Launches Falcon Router Agent For Biopharma(RTTNews) - Veeva Systems Inc. (VEEV), which provides cloud-based software for the life sciences industry, announced Veeva Falcon Router, an industry-specific agent designed to identify and route…Nasdaq
- Veeva Expands Amgen Partnership With Global Vault CRM Rollout PlanVEEV expands its decade-long Amgen partnership with a global Vault CRM rollout, reinforcing enterprise adoption and commercial subscription growth.NasdaqAMGN, VEEV, GMED, VCYT
- VanEck Morningstar Wide Moat ETF Experiences Big InflowLooking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the VanEck Morningstar Wide Moat ETF (Symbol: MOAT) where we have…NasdaqMOAT, VEEV, ABNB, LPLA
- Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to KnowVeeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.Nasdaq
- Veeva Systems Inc. (VEEV) Presents at Citi's 2026 Global TMT Conference TranscriptSeeking Alpha
- Veeva Systems Inc. (VEEV) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha
- VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate FastVeeva raises its fiscal 2027 outlook as Vault CRM adoption, R&D growth and Falcon AI momentum support expanding revenue and profitability.NasdaqVEEV, CRM, IQV
- Veeva: Will Benefit From AI And Increase Its RevenuesSeeking Alpha
- Veeva Systems: A Combination Of Growth, Margins, And Financial StrengthSeeking Alpha
- Veeva Systems Inc. (VEEV) Q2 2027 Earnings Call TranscriptSeeking Alpha
- Veeva Systems Inc. 2027 Q2 - Results - Earnings Call PresentationSeeking Alpha
- Can AI Innovation and CRM Wins Boost Veeva Systems' Q2 Results?VEEV heads into Q2 with Falcon AI, Vault CRM wins and R&D Cloud growth in focus as revenue and EPS estimates point to double-digit gains.NasdaqVEEV, MEDP, IQV
- Veeva Systems: A 'Buy' Because The Narrative Has Outrun The FundamentalsSeeking Alpha
- Veeva Systems: Steady Execution, Attractive P/E MultiplesSeeking Alpha
- Veeva: Strong Quality But Not A Risk-Free StockSeeking Alpha
- Veeva Systems: The AI Thesis Is More Tangible NowSeeking Alpha
- Veeva Systems Inc. 2027 Q1 - Results - Earnings Call PresentationSeeking Alpha